Package 43063-729-21

{"route": ["ORAL"], "spl_id": "39f936c5-d108-6804-e063-6394a90add94", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0343063729304"], "unii": ["0H73WJJ391"], "rxcui": ["199889"], "spl_set_id": ["9e516204-8f39-43c9-9f7e-d9777586f321"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "7 TABLET in 1 BOTTLE, PLASTIC (43063-729-07)", "package_ndc": "43063-729-07", "marketing_start_date": "20180307"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE, PLASTIC (43063-729-21)", "package_ndc": "43063-729-21", "marketing_start_date": "20170131"}, {"sample": false, "description": "28 TABLET in 1 BOTTLE, PLASTIC (43063-729-28)", "package_ndc": "43063-729-28", "marketing_start_date": "20161228"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (43063-729-30)", "package_ndc": "43063-729-30", "marketing_start_date": "20171231"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE, PLASTIC (43063-729-60)", "package_ndc": "43063-729-60", "marketing_start_date": "20161129"}], "brand_name": "Topiramate", "product_id": "43063-729_39f936c5-d108-6804-e063-6394a90add94", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "43063-729", "generic_name": "Topiramate", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "100 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20140612", "listing_expiration_date": "20261231"}